Science Explorer Back to mapMap
Discussion
Nonprofit · Regina · Canada

Saskatchewan Cancer Agency

In research, Saskatchewan Cancer Agency stands highest in Health Sciences (#12,773 of 16,688 worldwide), Medicine (#11,274 of 14,558 worldwide) and Life Sciences (#10,364 of 11,023 worldwide), over all time.

saskcancer.caROR OpenAlex
World rank, all time
#31,193
of 34,923
Rank in Canada
#636
of 718
Research works
421
▼ 2% vs 2018-21
Citations
12k
27.4 per fractional work
Top-10% rate
7.8%
all institutions 10.0%
vs its own fields
0.86×
1.00× is exactly expected
Open access
36%
world 40%
International
18%
world 18%
Saskatchewan Cancer Agency

What is Saskatchewan Cancer Agency known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #12,773 of 16,688 11.3%207
MedicineField #11,274 of 14,558 11.0%200
Life SciencesDomain #10,364 of 11,023 4.4%166

Each strip is that field's whole ranked pool, with the notch where Saskatchewan Cancer Agency sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Saskatchewan Cancer Agency work in?

In 2022-now, 68% of research at Saskatchewan Cancer Agency is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (65%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (4%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 33 fractional works · 67.8% of its workMedicine: 32 fractional works · 65.3% of its workOncology: 9 fractional works · 19.3% of its workPulmonary and Respiratory Medicine: 4 fractional works · 8.3% of its workHematology: 3 fractional works · 5.9% of its workEpidemiology: 2 fractional works · 4.8% of its workSurgery: 2 fractional works · 4.5% of its workGenetics: 1 fractional works · 2.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.4% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.6% of its workInfectious Diseases: 1 fractional works · 1.5% of its workPhysiology: 1 fractional works · 1.5% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.4% of its workPathology and Forensic Medicine: 1 fractional works · 1.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.0% of its workObstetrics and Gynecology: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.8% of its workHepatology: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.7% of its workPsychiatry and Mental health: 0 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.6% of its workInternal Medicine: 0 fractional works · 0.5% of its workRehabilitation: 0 fractional works · 0.5% of its workEmergency Medicine: 0 fractional works · 0.5% of its workGastroenterology: 0 fractional works · 0.5% of its workGeriatrics and Gerontology: 0 fractional works · 0.5% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workRheumatology: 0 fractional works · 0.3% of its workTransplantation: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.3% of its workUrology: 0 fractional works · 0.2% of its workFamily Practice: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 1.4% of its workGeneral Health Professions: 1 fractional works · 1.4% of its workVeterinary: 0 fractional works · 0.7% of its workSmall Animals: 0 fractional works · 0.7% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workLife Sciences: 12 fractional works · 25.4% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 20.9% of its workMolecular Biology: 5 fractional works · 11.3% of its workBiotechnology: 1 fractional works · 2.9% of its workCancer Research: 1 fractional works · 2.8% of its workGenetics: 1 fractional works · 1.4% of its workCell Biology: 1 fractional works · 1.3% of its workPhysiology: 0 fractional works · 0.5% of its workAging: 0 fractional works · 0.4% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 4.0% of its workImmunology: 2 fractional works · 3.8% of its workMicrobiology: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.0% of its workPhysical Sciences: 2 fractional works · 3.9% of its workPhysics and Astronomy: 1 fractional works · 1.3% of its workRadiation: 1 fractional works · 1.3% of its workComputer Science: 0 fractional works · 0.8% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.6% of its workComputational Theory and Mathematics: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 0.8% of its workBiomedical Engineering: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.8% of its workPollution: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 2.9% of its workSocial Sciences: 1 fractional works · 1.6% of its workHealth: 0 fractional works · 0.9% of its workSociology and Political Science: 0 fractional works · 0.5% of its workDemography: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.5% of its workClinical Psychology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workDecision Sciences: 0 fractional works · 0.3% of its workInformation Systems and Management: 0 fractional works · 0.3% of its workALL ITS WORKSaskatchewanCancer Agency49fractional works, 2022-now
Life Sciences25%Physical Sciences4%Health Sciences68%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine3265.3%
    2. Health Professions11.4%
    3. Veterinary00.7%
    4. Nursing00.5%
    1. Biochemistry, Genetics and Molecular Biology1020.9%
    2. Immunology and Microbiology24.0%
    3. Neuroscience00.5%
    4. Pharmacology, Toxicology and Pharmaceutics00.0%
    1. Physics and Astronomy11.3%
    2. Computer Science00.8%
    3. Engineering00.8%
    4. Environmental Science00.8%
    5. Materials Science00.2%
    6. Mathematics00.1%
    1. Social Sciences11.6%
    2. Psychology00.5%
    3. Economics, Econometrics and Finance00.5%
    4. Decision Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.91× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 3.96× its world share, 2 worksImmunology and Micro…Neuroscience: 0.30× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.13× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.10× its world share, 0 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringEnvironmental Science: 0.15× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.05× its world share, 0 worksMaterials ScienceMathematics: 0.06× its world share, 0 worksMathematicsPhysics and Astronomy: 0.59× its world share, 1 worksPhysics and AstronomyHealth Professions: 0.52× its world share, 1 worksHealth ProfessionsMedicine: 3.39× its world share, 32 worksMedicineNursing: 1.05× its world share, 0 worksNursingVeterinary: 5.04× its world share, 0 worksVeterinaryDecision Sciences: 0.37× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.21× its world share, 0 worksEconomics, Econometr…Psychology: 0.16× its world share, 0 worksPsychologySocial Sciences: 0.13× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 5.0×. Every wedge is a field page.

All 18 fields, with their numbers
  1. Veterinary5.04×0 works
  2. Immunology and Microbiology3.96×2 works
  3. Biochemistry, Genetics and Molecular Biology3.91×10 works
  4. Medicine3.39×32 works
  5. Nursing1.05×0 works
  6. Physics and Astronomy0.59×1 works
  7. Health Professions0.52×1 works
  8. Decision Sciences0.37×0 works
  9. Neuroscience0.30×0 works
  10. Economics, Econometrics and Finance0.21×0 works
  11. Psychology0.16×0 works
  12. Environmental Science0.15×0 works
  13. Pharmacology, Toxicology and Pharmaceutics0.13×0 works
  14. Social Sciences0.13×1 works
  15. Computer Science0.10×0 works
  16. Mathematics0.06×0 works
  17. Engineering0.05×0 works
  18. Materials Science0.05×0 works

Who are the top researchers at Saskatchewan Cancer Agency?

Ranked on the quality score, Thomas H. C. Barclay, Jon M. Tonita and Riaz Alvi lead among researchers whose main affiliation is Saskatchewan Cancer Agency.

  1. 1 Thomas H. C. Barclay Canada · #1,941,156 worldwide 1.2k citations · 36 works
  2. 2 Jon M. Tonita Canada · #2,036,834 worldwide 3.1k citations · 67 works
  3. 3 Riaz Alvi Canada · #2,262,603 worldwide 656 citations · 49 works
  4. 4 Manjunatha Ankathatti Munegowda Canada · #3,294,090 worldwide 722 citations · 32 works
  5. 5 Gavin Cranmer‐Sargison Canada · #3,524,460 worldwide 583 citations · 46 works
  6. 6 Carter Kolbeck Canada · #3,738,921 worldwide 515 citations · 20 works
  7. 7 Lynn Dwernychuk Canada · #4,191,865 worldwide 65 citations · 16 works
  8. 8 Joshua Giambattista Canada · #4,457,686 worldwide 482 citations · 25 works
  9. 9 Sylvia O Fedoruk Canada · #4,476,317 worldwide 460 citations · 28 works
  10. 10 R. Alvi Canada · #5,481,688 worldwide 39 citations · 19 works
All ranked researchers at Saskatchewan Cancer Agency

What are the most cited papers from Saskatchewan Cancer Agency?

The most cited paper from Saskatchewan Cancer Agency is "Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma" (James Edward Krook, C G Moertel, Leonard L. Gunderson et al., 1991), with 1,905 citations. Next come "Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial" (1,160) and "Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study" (1,083).

Most cited papers
#PaperReleasedCitations
1 Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma James Edward Krook, C G Moertel, Leonard L. Gunderson et al. · New England Journal of Medicine 14 Mar 1991 1,905
2 Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé et al. · Journal of Clinical Oncology Open access 28 Oct 2014 1,160
3 Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study Melina Arnold et al. · The Lancet Oncology Open access 11 Sep 2019 1,083
4 Adjuvant Docetaxel for Node-Positive Breast Cancer Miguel Martín et al. · New England Journal of Medicine Open access Jun 2005 957
5 Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001 Paul David Brown et al. · Journal of Clinical Oncology Open access 14 Feb 2020 858
All 61 most cited papers, with filters and sorting

Which keywords describe research at Saskatchewan Cancer Agency?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Cancer, Prognostic Factors, Immunotherapy, Breast Cancer, Clinical Practice Guidelines, Tumor Microenvironment and Survival Analysis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy5▲ 15×16 topics
  2. Cancer4▲ 6.3×22 topics
  3. Prognostic Factors3▲ 15×12 topics
  4. Breast Cancer3▲ 23×7 topics
  5. Epidemiology3▲ 1.52×17 topics
  6. Immunotherapy3▲ 8.4×12 topics
  7. Clinical Practice Guidelines3▲ 9.7×9 topics
  8. Quality of Life2▲ 3.4×7 topics
  9. Inflammation2▲ 2.0×13 topics
  10. Tumor Microenvironment2▲ 9.8×6 topics
  11. Survival Analysis2▲ 15×5 topics
  12. Radiotherapy2▲ 10×10 topics
  13. Cancer Therapy2▲ 6.3×11 topics
  14. Clinical Trials2▲ 5.6×6 topics
  15. Cancer Incidence2▲ 26×3 topics
  16. Hematopoietic Stem Cells2▲ 40×2 topics
  17. Neoadjuvant Therapy2▲ 14×4 topics
  18. Gene Therapy2▲ 17×4 topics
  19. Risk Factors2▲ 2.9×7 topics
  20. Cancer Risk2▲ 14×5 topics
  21. Metastatic Breast Cancer2▲ 54×2 topics
  22. Insulin Signaling1▲ 30×3 topics
  23. Molecular Subtypes1▲ 32×3 topics
  24. Receptor tyrosine kinases1▲ 69×2 topics
  25. Targeted Therapy1▲ 12×4 topics
  26. Apoptosis1▲ 7.7×8 topics
  27. Chemotherapy-Induced Peripheral Neuropathy1▲ 82×1 topic
  28. Electroporation1▲ 133×1 topic
  29. Irreversible Electroporation1▲ 133×1 topic
  30. Metastatic1▲ 39×2 topics
  31. Survival1▲ 18×4 topics
  32. Taxanes1▲ 82×1 topic
  33. AML1▲ 45×1 topic
  34. Acute Myeloid Leukemia1▲ 45×1 topic
  35. HER21▲ 73×1 topic
  36. Molecular Characterization1▲ 13×3 topics
  37. Population-Based Study1▲ 35×2 topics
  38. Therapeutic Targets1▲ 15×3 topics
  39. Trastuzumab1▲ 46×1 topic
  40. Tumor Suppression1▲ 30×3 topics

Which research topics does Saskatchewan Cancer Agency publish most on?

By volume in 2022-now: Microbial Inactivation Methods, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research and Acute Myeloid Leukemia Research.

Microbial Inactivation M…1Microbial Inactivation Methods: 1 fractional worksCancer Treatment and Pha…1Cancer Treatment and Pharmacology: 1 fractional worksHER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksAcute Myeloid Leukemia R…1Acute Myeloid Leukemia Research: 1 fractional worksMetabolism, Diabetes, and Cancer: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksLung Cancer Treatments a…1Lung Cancer Treatments and Mutations: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksCancer Risks and Factors: 1 fractional worksGastric Cancer Managemen…1Gastric Cancer Management and Outcomes: 1 fractional works
BiotechnologyOncologyHematologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Microbial Inactivation Methods Biotechnology 1 works
  2. 2 Cancer Treatment and Pharmacology Oncology 1 works
  3. 3 HER2/EGFR in Cancer Research Oncology 1 works
  4. 4 Acute Myeloid Leukemia Research Hematology 1 works
  5. 5 Metabolism, Diabetes, and Cancer Molecular Biology 1 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  8. 8 Immune Cell Function and Interaction Immunology 1 works
  9. 9 Cancer Risks and Factors Oncology 1 works
  10. 10 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.0%not open64.0%

World: 40% of research is openly available.

with international co-authors18.1%domestic only81.9%

World: 18% is written across borders.

How has Saskatchewan Cancer Agency's research output changed?

Output in 2022-2025 was 2% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Saskatchewan Cancer Agency as a percentage of every work published that year, 0.00022% in 2024.

still counting0.0010%0.0020%Saskatchewan Cancer Agency0.00021% in 202519801990200020102020

Fractional works of Saskatchewan Cancer Agency over all fractional works that year. How the balance of science has shifted.

Other research institutions in Regina

All research institutions in Regina

Share Saskatchewan Cancer Agency's ranking

Saskatchewan Cancer Agency on Science Explorer

A card with Saskatchewan Cancer Agency's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Saskatchewan Cancer Agency. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.